Average Co-Inventor Count = 4.79
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Smithkline Beecham Corporation (6 from 2,198 patents)
2. Cenes Limited (5 from 11 patents)
3. North Carolina State University (1 from 1,435 patents)
4. Glaxo Group Limited (1 from 1,168 patents)
5. Glaxosmithkline LLC (1 from 356 patents)
6. Gi Therapeutics, Inc. (1 from 8 patents)
15 patents:
1. 11582970 - 2-aminoimidazole-phenyl derivatives useful for controlling microbial growth
2. 10829490 - Substituted dihydropyrazino[1 ',2′:1,5]pyrrolo[2,3-d]pyrimidine-based antiproliferative agents
3. 7888503 - Benzodiazepine derivatives that inhibit rock
4. 7560467 - Indazolo-tetrahydropyrimidine-carboxamide derivative kinase inhibitors
5. 7528127 - Short-acting benzodiazepines
6. 7485635 - Short-acting benzodiazepines
7. 7473689 - Short-acting benzodiazepines
8. 7435730 - Short-acting benzodiazepines
9. 7279473 - Pyrazolopyridazine derivatives
10. 7166597 - Fused pyrazole derivatives being protein kinase inhibitors
11. 7163940 - Pyrazolopyridinyl pyrimidine therapeutic compounds
12. 7160880 - Short-acting benzodiazepines
13. 7109209 - Pyrazolopyridines, process for their preparation and use as therapeutic compounds
14. 7034030 - Pyralopyridines, process for their preparation and use as therapeutic compounds
15. 6756498 - Process for the preparation of chemical compounds